New laws in California and Canada, plus a high-profile UK medical case, have made it safer for nations to come out of the green closet
Three major developments in June, including the case of a British boy with severe epilepsy, are likely to accelerate international acceptance of marijuana.
On 11 June, Charlotte Caldwell landed at Heathrow airport with her 12-year-old son, Billy, with a six-month supply of cannabis oil, the most effective medicine shed found for her young childs epilepsy. She declared the medicine, which shed legally bought in Canada, to British border officials, who confiscated it, despite Caldwells pleas.
Unable to take his medicine, Billy was admitted just a few days later to hospital in life threatening condition. Sajid Javid, the home minister, was forced to issue an emergency license to allow doctors to treat Billy with cannabis oil.
The case sparked an outcry, and Javid called for a review of the UKs medical marijuana policy which recommended that clinicians should be able to prescribe medical marijuana. Inevitably, talk about full legalization has followed. According to recent polls, 82% of Britons support legalizing medical marijuana and 51% support full legalization.
Then on 19 June, Canadas parliament voted to become the first G7 nation to fully legalize, with legalization day scheduled for 17 October.
Afterwards, the senator Tony Dean told reporters: Weve just witnessed a very historic vote that ends 90 years of prohibition.
In an email, Peter Reynolds, the president of UK cannabis reform group Clear, called Billys situation has led to the most dramatic shift in drugs policy probably since [the Dangerous Drugs Act] of 1925.
Rounding out the month, on 25 June the US Food and Drug Administration approved, for the first time, a drug derived from the marijuana plant. The UK firm GW Pharmaceuticals invented the drug, Epidiolex, to treat two kinds of severe childhood epilepsy.
Relaxing attitudes in the US, and legalization in several states have made it safer for other nations to come out of the green closet. Despite the drugs goofy reputation, the subsequent shows of of interest demonstrate deep affinity for this plant in much of the world.
Read more: http://www.theguardian.com/us